Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc.（INFIQ）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
infiq · 股价预测 · 14 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Hold
14 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.00
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.00 | ↑ 0.00% |
1-day model range: $0–$0. Peak: $0 (+0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · INFIQ · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-02-24 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2022-11-16 | B. Riley Securities | Downgrade ↓ | Buy→Neutral |
| 2022-05-23 | Piper Sandler | Maintains | Overweight→Overweight |
| 2022-03-31 | Truist Securities | Maintains | Buy→Buy |
| 2022-03-30 | Piper Sandler | Maintains | Overweight→Overweight |
| 2021-08-02 | JP Morgan | Upgrade ↑ | Neutral→Overweight |
| 2021-07-28 | Wells Fargo | Upgrade ↑ | Equal Weight→Overweight |
| 2021-03-17 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2021-02-05 | JP Morgan | Upgrade ↑ | Underweight→Neutral |
| 2020-05-18 | B. Riley Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Infinity Pharmaceuticals, Inc. (INFIQ) stock. Of the recent 46 rating actions, 11 were upgrades and 13 were downgrades. 14 analysts currently cover INFIQ.
分析师推荐趋势
INFIQ analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$3M
↑ 0.0% YoY
Revenue Next Year
$4M
↑ 29.6% YoY
EPS This Year
$-0.46
EPS Next Year
$-0.55
↑ 19.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast INFIQ EPS of $-0.46 for the current fiscal year, based on estimates from 1 analysts. The INFIQ revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
INFIQ 股价预测由两类独立数据源支撑：来自 14 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。INFIQ 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Hold。
INFIQ 的短期预测（明日）为 $0.00（+0.00%）。
Infinity Pharmaceuticals, Inc. 在 OTC 上市，代码 INFIQ。INFIQ 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 36% 对应 Hold 共识。
常见问题
INFIQ 预测 · 8 个问题根据 14 位华尔街分析师，INFIQ 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.00，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.